drugset / Trial / NCT02258282
Safety and Efficacy of Etanercept in Patients With Psoriasis
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate safety and efficacy of etanercept in patients with psoriasis who had an unsatisfactory response to traditional DMARDs.
Timeline
- Start
- 2014-05
- Primary completion
- 2022-12
- Completion
- 2022-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 50 mg | — |